Bancreek Capital Management, LP Becton Dickinson & CO Transaction History

Bancreek Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$229.71 - $259.35 $599,772 - $677,162	2,611 Added 14.48%	20,644 $5.11 Million
Q4 2022 Feb 08, 2023	BUY	$218.29 - $256.91 $186,419 - $219,401	854 Added 4.97%	18,033 $4.59 Million
Q3 2022 Nov 09, 2022	SELL	$51.03 - $264.23 $214,632 - $1.11 Million	-4,206 Reduced 19.67%	17,179 $3.83 Million
Q2 2022 Aug 09, 2022	BUY	$234.74 - $275.42 $138,731 - $162,773	591 Added 2.84%	21,385 $5.27 Million
Q1 2022 May 09, 2022	BUY	$243.64 - $270.48 $1.92 Million - $2.14 Million	7,894 Added 61.19%	20,794 $5.53 Million
Q4 2021 Feb 09, 2022	BUY	$230.08 - $250.94 $2.97 Million - $3.24 Million	12,900 New	12,900 $3.24 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Bancreek Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bancreek Capital Management, LP with notifications on news.